Asset Publisher

MOH Calls Women to Participate in National Study for Early Detection of Cervical Cancer

MOH Calls Women to Participate in National Study for Early Detection of Cervical Cancer

MOH Calls Women to Participate in National Study for Early Detection of Cervical Cancer




The Ministry of Health (MOH), represented by the Department of Woman and Child Health, in cooperation with the Royal Hospital and United Nations Population Fund (UNFPA), launched today (Thursday) a National Study for Early Detection of Cervical Cancer.

The launching ceremony was held under the patronage of H.E. Dr. Said Harib Al-Lamki, MOH Undersecretary for Health Affairs with the presence of a number of MOH director generals, directors, and heads of health institutions.

In this regard, Dr. Badria Al-Rashdi, Director General of Primary Health Care stressed that the Sultanate of Oman has paid special attention to women and child health since the beginning of the seventies through launching pregnant health programs, birth spacing programs, child programs, infertility treatment programs… etc.

“Today, we launch a national study on HPV prevalence and genotyping among Omani women, which is part of the Sultanate’s commitment to the Global Strategy for the elimination of cervical cancer, in all governorates” Dr. Badria Al-Rashdi said.         

Dr. Jamila Al-Abri, Director of Woman and Child Health pointed out that the number of infected cases in Oman was 35 cases with an average of four per 100000 populations. Therefore, it has been decided to conduct a national study to measure the prevalence rate and genotypes of human papillomavirus (HPV) among Omani women.

She added that the study will be conducted by a group of researchers from the Woman and Child Health Department, the Obstetrics and Gynecology Department & the Histology Laboratory at the Royal Hospital, the Central Public Health Laboratory with support from the UNFPA, WHO and Centers for Disease Control & Prevention (CDC).

Moreover, the Director of Woman and Child Health addressed that 51 physicians from various 28 health institutions were trained theoretically on the causes and treatment of cervical cancer, as well as practically on taking Pap smears. The samples will be examined in the Histology lab of the Royal Hospital and the Central Public Health Lab. 

Dr. Lamia Mahmoud, Regional Adviser from the WHO, indicated that in 2020, the World Health Assembly adopted the Global strategy to eliminate cervical cancer. The strategy has been endorsed by many countries including the Sultanate of Oman. The Global Strategy is based on three aspects; primary prevention by providing human papillomavirus (HPV) vaccination, early detection through the Pap smear, and treatment.

The Ministry of Health calls upon all women between the ages of 25-49 years to head to participate in the study, as it is an opportunity to early detect cervical cancer (before symptoms appear) and avoid reaching the late stages of the disease.